California Medicaid Enrollment and Melanoma Stage at Diagnosis. A Population-Based Study

American Journal of Preventive Medicine

Volumn 35, Issue 1, 2008, Pages 7-13

  Pollitt, Ricardo A ^a   Clarke, Christina A ^c,d   Shema, Sarah J ^d   Swetter, Susan M ^b,e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d NORTHERN CALIFORNIA CANCER CENTER   (United States)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AWARENESS; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CONFIDENCE INTERVAL; CONTROLLED STUDY; COVARIANCE; ETHNICITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL EDUCATION; MELANOMA; METASTASIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEGRO; POPULATION; POPULATION RESEARCH; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADOLESCENT; ADULT; CALIFORNIA; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEDICAID; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; SKIN NEOPLASMS; SOCIAL CLASS; UNITED STATES;

EID: 44649188480     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2008.03.026     Document Type: Article

References (26)

1. Markovic S.N., Erickson L.A., Rao R.D., Weenig R.H., Pockaj B.A., Bardia A., et al. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc 82 (2007) 490-513
2. Ortiz C.A., Goodwin J.S., and Freeman J.L. The effect of socioeconomic factors on incidence, stage at diagnosis and survival of cutaneous melanoma. Med Sci Monit 11 (2005) RA163-RA172
3. Byrd K.M., Wilson D.C., Hoyler S.S., and Peck G.L. Advanced presentation of melanoma in African Americans. J Am Acad Dermatol 50 (2004) 21-24 discussion 142-3
4. Cockburn M.G., Zadnick J., and Deapen D. Developing epidemic of melanoma in the Hispanic population of California. Cancer 106 (2006) 1162-1168
5. Hemmings D.E., Johnson D.S., Tominaga G.T., and Wong J.H. Cutaneous melanoma in a multiethnic population: is this a different disease?. Arch Surg 139 (2004) 968-972 discussion 972-3
6. Chang A.E., Karnell L.H., and Menck H.R. The national cancer data base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 83 (1998) 1664-1678
7. Roetzheim R.G., Pal N., Tennant C., Voti L., Ayanian J.Z., Schwabe A., et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 91 (1999) 1409-1415
8. Van Durme D.J., Ferrante J.M., Pal N., Wathington D., Roetzheim R.G., and Gonzalez E.C. Demographic predictors of melanoma stage at diagnosis. Arch Fam Med 9 (2000) 606-611
9. Bradley C.J., Given C.W., and Roberts C. Late stage cancers in a Medicaid-insured population. Med Care 41 (2003) 722-728
10. Koroukian S.M. Assessing the effectiveness of Medicaid in breast and cervical cancer prevention. J Public Health Manag Pract 9 (2003) 306-314
11. O'Malley C.D., Shema S.J., Clarke L.S., Clarke C.A., and Perkins C.I. Medicaid status and stage at diagnosis of cervical cancer. Am J Public Health 96 (2006) 2179-2185
12. Perkins C.I., Wright W.E., Allen M., Samuels S.J., and Romano P.S. Breast cancer stage at diagnosis in relation to duration of medicaid enrollment. Med Care 39 (2001) 1224-1233
13. McLaughlin C., Hotes J., and Wu X.C. Cancer in North America, 1997-2001, Volume 1: Incidence (2004), North American Association of Central Cancer Registries, Springfield IL
14. Diez-Roux A.V., Kiefe C.I., Jacobs Jr. D.R., et al. Area characteristics and individual-level socioeconomic position indicators in three population-based epidemiologic studies. Ann Epidemiol 11 (2001) 395-405
15. Krieger N., Williams D.R., and Moss N.E. Measuring social class in U.S. public health research: concepts, methodologies, and guidelines. Annu Rev Public Health 18 (1997) 341-378
16. Woolf S.H., Johnson R.E., and Geiger H.J. The rising prevalence of severe poverty in America: a growing threat to public health. Am J Prev Med 31 (2006) 332-341
17. Percy C., Van Holten V., and Muir C. International classification of diseases for oncology (1995), WHO, Geneva
18. Balch C.M., Buzaid A.C., Soong S.J., et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19 (2001) 3635-3648
19. Carli P., De Giorgi V., Palli D., et al. Patterns of detection of superficial spreading and nodular-type melanoma: a multicenter Italian study. Dermatol Surg 30 (2004) 1371-1375 discussion 1375-6
20. Roetzheim R.G., Gonzalez E.C., Ferrante J.M., Pal N., Van Durme D.J., and Krischer J.P. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer 89 (2000) 2202-2213
21. Singh G.K., Miller B.A., Hankey B.F., and Edwards B.K. Area socioeconomic variations in U.S. cancer incidence, mortality, stage, treatment, and survival, 1975-1999 (2003), National Cancer Institute, Bethesda MD
22. Epstein D.S., Lange J.R., Gruber S.B., Mofid M., and Koch S.E. Is physician detection associated with thinner melanomas?. JAMA 281 (1999) 640-643
23. Cress R.D., and Holly E.A. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California cancer registry data, 1988-93. Cancer Causes Control 8 (1997) 246-252
24. Jemal A., Devesa S.S., Hartge P., and Tucker M.A. Recent trends in cutaneous melanoma incidence among whites in the U.S. J Natl Cancer Inst 93 (2001) 678-683
25. Demierre M.F., Chung C., Miller D.R., and Geller A.C. Early detection of thick melanomas in the U.S.: beware of the nodular subtype. Arch Dermatol 141 (2005) 745-750
26. Chan J.K., Gomez S.L., O'Malley C.D., Perkins C.I., and Clarke C.A. Validity of cancer registry Medicaid status against enrollment files: implications for population-based studies of cancer outcomes. Med Care 44 (2006) 952-955